BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $261,000 | -99.2% | 261,000 | -98.9% | 0.00% | -100.0% |
| Q2 2020 | $31,103,000 | +9.4% | 23,672,000 | -11.7% | 0.01% | 0.0% |
| Q1 2020 | $28,428,000 | +116.0% | 26,817,000 | +121.3% | 0.01% | +150.0% |
| Q4 2019 | $13,163,000 | -64.5% | 12,117,000 | -66.3% | 0.00% | -66.7% |
| Q3 2019 | $37,076,000 | -7.5% | 36,002,000 | +0.7% | 0.01% | 0.0% |
| Q2 2019 | $40,069,000 | +31.8% | 35,736,000 | +33.6% | 0.01% | +20.0% |
| Q1 2019 | $30,410,000 | +67.4% | 26,756,000 | +63.8% | 0.01% | +66.7% |
| Q4 2018 | $18,171,000 | +18.5% | 16,334,000 | +27.7% | 0.00% | +50.0% |
| Q3 2018 | $15,339,000 | +158.6% | 12,787,000 | +155.3% | 0.00% | +100.0% |
| Q2 2018 | $5,932,000 | -3.7% | 5,008,000 | -10.4% | 0.00% | 0.0% |
| Q1 2018 | $6,158,000 | +214.3% | 5,592,000 | +238.1% | 0.00% | – |
| Q4 2017 | $1,959,000 | -2.9% | 1,654,000 | -1.8% | 0.00% | – |
| Q3 2017 | $2,017,000 | +1.1% | 1,685,000 | +0.4% | 0.00% | – |
| Q2 2017 | $1,996,000 | -85.9% | 1,678,000 | -86.0% | 0.00% | -100.0% |
| Q1 2017 | $14,157,000 | -12.9% | 11,991,000 | -13.5% | 0.00% | -25.0% |
| Q4 2016 | $16,249,000 | -7.7% | 13,866,000 | -1.8% | 0.00% | 0.0% |
| Q3 2016 | $17,612,000 | +94.2% | 14,125,000 | +80.1% | 0.00% | +100.0% |
| Q2 2016 | $9,067,000 | +215.2% | 7,842,000 | +223.2% | 0.00% | +100.0% |
| Q1 2016 | $2,877,000 | -67.5% | 2,426,000 | -63.3% | 0.00% | -50.0% |
| Q4 2015 | $8,839,000 | -34.9% | 6,615,000 | -34.5% | 0.00% | -33.3% |
| Q3 2015 | $13,569,000 | +206.1% | 10,098,000 | +262.7% | 0.00% | +200.0% |
| Q2 2015 | $4,433,000 | -44.0% | 2,784,000 | -46.7% | 0.00% | -66.7% |
| Q1 2015 | $7,914,000 | +131800.0% | 5,226,000 | +104420.0% | 0.00% | – |
| Q4 2014 | $6,000 | -99.0% | 5,000 | -99.1% | 0.00% | – |
| Q3 2014 | $622,000 | +57.9% | 568,000 | +51.9% | 0.00% | – |
| Q2 2014 | $394,000 | -45.8% | 374,000 | -42.9% | 0.00% | – |
| Q1 2014 | $727,000 | -77.2% | 655,000 | -78.0% | 0.00% | -100.0% |
| Q4 2013 | $3,182,000 | – | 2,976,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|